54.30
price down icon0.33%   -0.18
pre-market  Pre-market:  54.79   0.49   +0.90%
loading
Globus Medical Inc stock is traded at $54.30, with a volume of 1.18M. It is down -0.33% in the last 24 hours and down -7.34% over the past month. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$54.48
Open:
$54.49
24h Volume:
1.18M
Relative Volume:
0.75
Market Cap:
$7.35B
Revenue:
$2.51B
Net Income/Loss:
$185.56M
P/E Ratio:
40.52
EPS:
1.34
Net Cash Flow:
$517.59M
1W Performance:
+4.64%
1M Performance:
-7.34%
6M Performance:
-41.58%
1Y Performance:
-24.47%
1-Day Range:
Value
$53.78
$54.78
1-Week Range:
Value
$52.01
$54.78
52-Week Range:
Value
$51.87
$94.93

Globus Medical Inc Stock (GMED) Company Profile

Name
Name
Globus Medical Inc
Name
Phone
610-930-1800
Name
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Name
Employee
5,300
Name
Twitter
@GlobusMedical
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
GMED's Discussions on Twitter

Compare GMED with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
GMED
Globus Medical Inc
54.30 7.38B 2.51B 185.56M 517.59M 1.34
Medical Devices icon
ABT
Abbott Laboratories
126.35 220.16B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
105.84 157.03B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
400.69 154.21B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.97 119.08B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.49 46.93B 5.69B 4.15B 623.10M 6.95

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Date Action Analyst Rating Change
May-27-25 Downgrade BTIG Research Buy → Neutral
Jan-10-25 Upgrade BofA Securities Underperform → Neutral
Dec-02-24 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-07-24 Upgrade Wells Fargo Equal Weight → Overweight
May-20-24 Upgrade Piper Sandler Neutral → Overweight
Mar-18-24 Upgrade BTIG Research Neutral → Buy
Oct-20-23 Initiated ROTH MKM Buy
Sep-19-23 Upgrade Stifel Hold → Buy
Mar-30-23 Upgrade Canaccord Genuity Hold → Buy
Feb-13-23 Downgrade BofA Securities Buy → Underperform
Feb-10-23 Downgrade BTIG Research Buy → Neutral
Feb-10-23 Downgrade Loop Capital Buy → Hold
Feb-10-23 Downgrade Needham Buy → Hold
Feb-10-23 Downgrade Truist Buy → Hold
Feb-10-23 Downgrade Wells Fargo Overweight → Equal Weight
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Apr-13-22 Resumed Truist Buy
Mar-28-22 Initiated Wells Fargo Overweight
Jan-04-22 Upgrade Piper Sandler Neutral → Overweight
Dec-13-21 Upgrade BofA Securities Underperform → Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Oct-29-21 Initiated Loop Capital Buy
Feb-18-21 Resumed Needham Buy
Dec-08-20 Initiated Citigroup Buy
Oct-20-20 Initiated Stifel Hold
Aug-06-20 Reiterated Needham Buy
Aug-06-20 Upgrade Northland Capital Market Perform → Outperform
Jul-21-20 Initiated Northland Capital Market Perform
Jul-06-20 Downgrade Piper Sandler Overweight → Neutral
May-08-20 Reiterated Needham Buy
Mar-18-20 Upgrade BTIG Research Neutral → Buy
Jan-08-20 Initiated SunTrust Buy
Dec-12-19 Upgrade Wells Fargo Market Perform → Outperform
Aug-02-19 Reiterated Needham Buy
May-24-19 Downgrade Wells Fargo Outperform → Market Perform
May-03-19 Reiterated Needham Buy
Feb-28-19 Upgrade UBS Neutral → Buy
Jan-02-19 Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-02-18 Reiterated Needham Buy
Jun-27-18 Downgrade BofA/Merrill Neutral → Underperform
Jun-01-18 Initiated Cantor Fitzgerald Overweight
May-03-18 Reiterated Needham Buy
Apr-04-18 Upgrade Needham Hold → Buy
View All

Globus Medical Inc Stock (GMED) Latest News

pulisher
Jul 28, 2025

Canaccord Downgrades Globus Medical (GMED) PT to $90, Maintains Buy Rating - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

Real time social sentiment graph for Globus Medical Inc. Free ROI Driven Equity Selection With Safety - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive Globus Medical Inc. stock higher in 2025Invest smarter with real-time trading alerts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Globus Medical Inc. company’s key revenue driversBest Dividend Updates From AI Tools - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

When is Globus Medical Inc. stock expected to show significant growthConsistent high-yield stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Globus Medical Inc. stock price move sharplyBuild a portfolio that outperforms the market - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Globus Medical Names Keith Pfeil as CEO, Posts Strong Q2 Sales Growth - MSN

Jul 27, 2025
pulisher
Jul 26, 2025

Why Globus Medical Inc. stock attracts strong analyst attentionFree VIP Group - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Is Globus Medical Inc. a good long term investmentSuperior stock selection - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Globus Medical Introduces DuraPro with Navigation to Enhance Surgical Workflows, Safety - MSN

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Globus Medical Inc. stock priceHigh-yield growth strategies - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Orthobiologics Market Growth in Future Scope 2025-2032 | Zimmer Biomet, Bone Biologics Corp., Globus Medical - openPR.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Globus Medical Inc. stockFree Predictions - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Globus promotes Keith Pfeil to CEO as former exec leaves for Dentsply - MedTech Dive

Jul 22, 2025
pulisher
Jul 22, 2025

Globus Medical Inc. Stock Analysis and ForecastFree Stock Market Mentorship - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Globus Medical to Announce Q2 2025 Financial Results on August 7, Followed by Investor Call - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Spinal Non-Fusion Technologies Market Set to Witness - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

Hold Rating on Globus Medical Amid Management Changes and Spine Business Concerns - TipRanks

Jul 22, 2025
pulisher
Jul 21, 2025

Globus Medical CEO leaves for Dentsply Sirona corner office - MassDevice

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical Appoints Keith Pfeil as CEO - citybiz

Jul 21, 2025
pulisher
Jul 21, 2025

Avantor and Globus Medical appoint new CEOs - The Business Journals

Jul 21, 2025
pulisher
Jul 21, 2025

What You Can Learn From Globus Medical, Inc.'s (NYSE:GMED) P/E - simplywall.st

Jul 21, 2025
pulisher
Jul 21, 2025

Why Globus Medical (GMED) Shares Are Trading Lower Today - TradingView

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical stock holds steady as Needham maintains rating amid CEO change - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

Globus CEO leaving, analysts see replacement as steady hand - BioWorld MedTech

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical's Leadership Transition: A Strategic Catalyst for Long-Term Growth in the Medical Technology Sector - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical's Leadership Transition and Growth Potential in a Post-Merger Landscape - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Keith Pfeil to Lead Globus Medical (GMED) as CEO from July 2025 - GuruFocus

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical stock hits 52-week low at 53.54 USD By Investing.com - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

Daniel Scavilla Named CEO of Dentsply Sirona - Dentistry Today

Jul 21, 2025
pulisher
Jul 21, 2025

Dentsply Sirona Hires Globus CEO Daniel Scavilla as Chief Exec - Medical Product Outsourcing

Jul 21, 2025
pulisher
Jul 21, 2025

Impingement Syndrome Market Growing with Musculoskeletal - openPR.com

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical Announces New CEO and CFO - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical appoints Keith Pfeil as new CEO, reports Q2 sales growth By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical appoints Keith Pfeil as new CEO, reports Q2 sales growth - Investing.com Nigeria

Jul 21, 2025
pulisher
Jul 21, 2025

Dentsply Sirona Appoints Daniel Scavilla as President and CEO, Effective August 1, 2025 - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical sees Q2 revenue $745.3M, consensus $738.91M - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical (GMED) Posts Strong Sales Growth in Q2 2025 | GME - GuruFocus

Jul 21, 2025
pulisher
Jul 21, 2025

Former Globus Medical CEO Takes Helm at Dentsply Sirona as Q2 Sales Hit $935M - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical's Leadership Transition and Q2 Sales Performance: A Strategic Blueprint for Sustained Growth in Musculoskeletal Tech - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical Appoints Keith Pfeil as New President and CEO, Carl Kline as CFO - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

Globus Medical Expands Surgical Navigation Portfolio With Advanced DuraPro Oscillating System - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

GMED names new CEO & CFO after sudden resignation – compensation, details - Stock Titan

Jul 21, 2025

Globus Medical Inc Stock (GMED) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$292.27
price up icon 0.71%
medical_devices STE
$226.53
price down icon 1.71%
medical_devices PHG
$25.66
price down icon 1.91%
$89.53
price up icon 0.61%
$77.74
price up icon 0.17%
medical_devices EW
$78.49
price down icon 1.89%
Cap:     |  Volume (24h):